Analysis of genetic impact on smell impairment in patients with hereditary angioedema type 1 and 2
J Dtsch Dermatol Ges
.
2021 Jul;19(7):1060-1062.
doi: 10.1111/ddg.14417.
Epub 2021 May 20.
Authors
Ulrike Förster-Ruhrmann
1
,
Greta Pierchalla
2
,
Christiane Stieber
3
,
Stefanie Heilmann-Heimbach
4
,
Sven Cichon
5
6
7
,
Markus M Nöthen
4
,
André Ellrich
8
,
Heidi Olze
1
2
,
Marcus Maurer
8
,
Markus Magerl
8
Affiliations
1
Department of Oto-Rhino-Laryngology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
2
Department of Oto-Rhino-Laryngology, Campus Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
3
Center for Rare Diseases Bonn (ZSEB), University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
4
Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
5
Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
6
Department of Biomedicine, University of Basel, Basel, Switzerland.
7
Institute of Neuroscience and Medicine (INM-1), Research Center Juelich, Juelich, Germany.
8
Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
PMID:
34015192
DOI:
10.1111/ddg.14417
No abstract available
Publication types
Letter
MeSH terms
Angioedema*
Angioedemas, Hereditary* / diagnosis
Angioedemas, Hereditary* / genetics
Complement C1 Inhibitor Protein / genetics
Humans
Smell
Substances
Complement C1 Inhibitor Protein